Drugs License Approval: A Mandate for Good Manufacturing Practices by DCGI Commitment to Quality: Ensuring Pharmaceutical Excellence In an epoch-making move, the Drugs Controller General of India (DCGI) firmly positions itself in the advancement of drug safety. Aligning with a surge in the Indian pharmaceutical sector, currently boasting a $65 billion valuation, the key stipulation for licenses is enforcement. With a prominent spotlight on Good Manufacturing Practices (GMP), the DCGI underscores the critical nature of […]